|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
These excerpts taken from the LLY 10-K filed Feb 27, 2009. Executive
Officers of the Company
The following table sets forth certain information regarding our
executive officers. All executive officers except Mr. Azar
have been employed by the Company in executive positions during
the last five years.
The term of office for each executive officer expires on the
date of the annual meeting of the Board of Directors, to be held
on April 20, 2009, or on the date his or her successor is
chosen and qualified. No director or executive officer of the
Company has a family relationship with any other
director or executive officer of the Company, as that term is
defined for purposes of this disclosure requirement. There is no
understanding between any executive officer and any other person
pursuant to which the executive officer was selected.
Executive Officers of the Company The following table sets forth certain information regarding our executive officers. All executive officers except Mr. Azar have been employed by the Company in executive positions during the last five years. The term of office for each executive officer expires on the date of the annual meeting of the Board of Directors, to be held on April 20, 2009, or on the date his or her successor is chosen and qualified. No director or executive officer of the Company has a family relationship with any other director or executive officer of the Company, as that term is defined for purposes of this disclosure requirement. There is no understanding between any executive officer and any other person pursuant to which the executive officer was selected.
These excerpts taken from the LLY 10-K filed Oct 21, 2008. Executive
Officers of the Company
The following table sets forth certain information regarding our
executive officers. All executive officers have been employed by
the Company in executive positions during the last five years.
The term of office for each executive officer expires on the
date of the annual meeting of the Board of Directors, to be held
on April 21, 2008, or on the date his or her successor is
chosen and qualified. No director or executive officer of the
Company has a family relationship with any other
director or executive officer of the Company, as that term is
defined for purposes of this disclosure requirement. There is no
understanding between any executive officer and any other person
pursuant to which the executive officer was selected.
Mr. Taurel will retire as Chief Executive Officer as of
March 31, 2008, and as Chairman and a director as of
December 31, 2008. On April 1, 2008,
Dr. Lechleiter will become President and Chief Executive
Officer. Dr. Tallarigo will retire as of March 31,
2008, and on April 1, 2008, Bryce D. Carmine will become
Executive Vice President, Marketing and Sales.
Executive Officers of the Company The following table sets forth certain information regarding our executive officers. All executive officers have been employed by the Company in executive positions during the last five years. The term of office for each executive officer expires on the date of the annual meeting of the Board of Directors, to be held on April 21, 2008, or on the date his or her successor is chosen and qualified. No director or executive officer of the Company has a family relationship with any other director or executive officer of the Company, as that term is defined for purposes of this disclosure requirement. There is no understanding between any executive officer and any other person pursuant to which the executive officer was selected.
Mr. Taurel will retire as Chief Executive Officer as of March 31, 2008, and as Chairman and a director as of December 31, 2008. On April 1, 2008, Dr. Lechleiter will become President and Chief Executive Officer. Dr. Tallarigo will retire as of March 31, 2008, and on April 1, 2008, Bryce D. Carmine will become Executive Vice President, Marketing and Sales. These excerpts taken from the LLY 10-K filed Feb 29, 2008. Executive
Officers of the Company
The following table sets forth certain information regarding our
executive officers. All executive officers have been employed by
the Company in executive positions during the last five years.
The term of office for each executive officer expires on the
date of the annual meeting of the Board of Directors, to be held
on April 21, 2008, or on the date his or her successor is
chosen and qualified. No director or executive officer of the
Company has a family relationship with any other
director or executive officer of the Company, as that term is
defined for purposes of this disclosure requirement. There is no
understanding between any executive officer and any other person
pursuant to which the executive officer was selected.
Mr. Taurel will retire as Chief Executive Officer as of
March 31, 2008, and as Chairman and a director as of
December 31, 2008. On April 1, 2008,
Dr. Lechleiter will become President and Chief Executive
Officer. Dr. Tallarigo will retire as of March 31,
2008, and on April 1, 2008, Bryce D. Carmine will become
Executive Vice President, Marketing and Sales.
Executive Officers of the Company The following table sets forth certain information regarding our executive officers. All executive officers have been employed by the Company in executive positions during the last five years. The term of office for each executive officer expires on the date of the annual meeting of the Board of Directors, to be held on April 21, 2008, or on the date his or her successor is chosen and qualified. No director or executive officer of the Company has a family relationship with any other director or executive officer of the Company, as that term is defined for purposes of this disclosure requirement. There is no understanding between any executive officer and any other person pursuant to which the executive officer was selected.
Mr. Taurel will retire as Chief Executive Officer as of March 31, 2008, and as Chairman and a director as of December 31, 2008. On April 1, 2008, Dr. Lechleiter will become President and Chief Executive Officer. Dr. Tallarigo will retire as of March 31, 2008, and on April 1, 2008, Bryce D. Carmine will become Executive Vice President, Marketing and Sales. This excerpt taken from the LLY 10-K filed Feb 28, 2007. Executive
Officers of the Company
The following table sets forth certain information regarding our
executive officers. All executive officers have been employed by
the Company in executive positions during the last five years.
The term of office for each executive officer expires on the
date of the annual meeting of the Board of Directors, to be held
on April 16, 2007, or on the date his or her successor is
chosen and qualified. No director or executive officer of the
Company has a family relationship with any other
director or executive officer of the Company, as that term is
defined for purposes of this disclosure requirement. There is no
understanding between any executive officer and any other person
pursuant to which the executive officer was selected.
| EXCERPTS ON THIS PAGE:
RELATED TOPICS for LLY: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||